Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Vimian in connection with a directed share issue of approximately MSEK 1,500
Mandate

Vinge advises Vimian in connection with a directed share issue of approximately MSEK 1,500

September 16, 2022 Capital Markets and Public M&A Life Sciences & Health

Vinge advises Vimian in connection with a directed share issue of approximately MSEK 1,500, before issue costs.

The share issue is in part based on an authorization and in part subject to a resolution from an extraordinary general meeting. The company’s shares are admitted to trading on Nasdaq Stockholm.

Vinge’s team has consisted of Dain Hård Nevonen, Linnéa Sellström, Anders Sundin Lundberg and Anna Svensson.

Related

Vinge has advised Investor in connection with acquisition of shares in EQT

 Vinge has advised Investor in connection with an acquisition of 12,500,000 shares in EQT AB from Wallenberg Investments for a total consideration of approximately SEK 3.5 billion.
October 19, 2026

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026